Liontos, M.; Svarna, A.; Theofanakis, C.; Fiste, O.; Andrikopoulou, A.; Kaparelou, M.; Koutsoukos, K.; Thomakos, N.; Haidopoulos, D.; Rodolakis, A.;
et al. What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience. Curr. Oncol. 2021, 28, 4862-4873.
https://doi.org/10.3390/curroncol28060410
AMA Style
Liontos M, Svarna A, Theofanakis C, Fiste O, Andrikopoulou A, Kaparelou M, Koutsoukos K, Thomakos N, Haidopoulos D, Rodolakis A,
et al. What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience. Current Oncology. 2021; 28(6):4862-4873.
https://doi.org/10.3390/curroncol28060410
Chicago/Turabian Style
Liontos, Michalis, Anna Svarna, Charalampos Theofanakis, Oraianthi Fiste, Angeliki Andrikopoulou, Maria Kaparelou, Konstantinos Koutsoukos, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis,
and et al. 2021. "What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience" Current Oncology 28, no. 6: 4862-4873.
https://doi.org/10.3390/curroncol28060410
APA Style
Liontos, M., Svarna, A., Theofanakis, C., Fiste, O., Andrikopoulou, A., Kaparelou, M., Koutsoukos, K., Thomakos, N., Haidopoulos, D., Rodolakis, A., Dimopoulos, M. A., & Zagouri, F.
(2021). What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience. Current Oncology, 28(6), 4862-4873.
https://doi.org/10.3390/curroncol28060410